MAPT and Cognitive impairment: In addition to its ability to reduce Aβ production and tau phosphorylation, Rps23rg1/RPS23RG1 overexpression attenuates oAβ-induced synaptic and cognitive impairments by restoring PKA activity, which subsequently leads to enhanced CREB activity and decreased GSK-3β activity and tau phosphorylation.